Annals of Pharmacotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 42.7% | 0.815 | Q2 | 77.9% |
| 2024 | 2.3 | Q3 | 43.1% | 0.788 | Q2 | 77.4% |
| 2023 | 2.3 | Q3 | 45.6% | 0.779 | Q2 | 78.9% |
| 2022 | 2.9 | Q3 | 51.2% | 0.891 | Q1 | 83.5% |
| 2021 | 3.5 | Q3 | 58.9% | 0.756 | Q2 | 79.6% |
| 2020 | — | — | 0.926 | Q2 | 83.5% | |
| 2019 | — | — | 0.865 | Q1 | 82.3% | |
| 2018 | — | — | 0.909 | Q1 | 82.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1542-6270
ISSN
1060-0280
country
UScoverage
1981, 1983, 1985, 1987, 1990-2026